S

Sanofi

Global pharma company; vaccines and R&D

Global Product Owner and Delivery Lead for Printing Services

Full-TimeDeadline 12/15/26
No salary listed
Senior, Expert
Bachelor's, Master's, MBA
Hyderabad, Telangana, India
In Person
IT Operations

About the job

Requirements
  • A Bachelor's degree in Information Technology, Computer Science, Business Administration, Supply Chain Management, or a related field is required.
  • At least 8–10 years of experience in IT service delivery, managed services, or vendor management is required.
  • At least 3–5 years of experience managing global Digital services or infrastructure platforms is required.
  • Demonstrated experience managing large-scale managed service contracts, including budget accountability, is required; experience with multi-million-dollar contracts is preferred.
  • Demonstrated experience in product ownership, roadmap definition, or platform management is required.
  • Experience managing third-party vendors or managed service providers in a global, multi-site environment is required.
  • A strong understanding of Office Printing technologies, including Multi-Functional Printers, and M&S Printing technologies such as Zebra, label, and thermal printers, as well as print servers, print management software, and mobile/cloud printing solutions is required.
  • Proficiency in IT service management frameworks, particularly ITIL, including incident, problem, change, and service level management, is required.
  • Strong budget management and financial analysis skills, including forecasting, variance analysis, and cost optimization, are required.
  • Ability to define and manage technology roadmaps, prioritize initiatives, and balance business value with technical feasibility is required.
  • An understanding of platform management concepts, including infrastructure, monitoring, security, and disaster recovery, is required.
  • Experience working in Agile environments with product management principles, including roadmap definition, backlog prioritization, and sprint planning, is required.
Responsibilities
  • Lead the global managed services contract for Office and M&S Printing Services, ensuring the vendor meets agreed service level agreements, key performance indicators, and contractual commitments across all company locations.
  • Define, monitor, and enforce service level agreements and key performance indicators for the managed service provider; conduct monthly or quarterly business reviews and drive corrective actions for underperformance.
  • Serve as the primary escalation point for vendor performance issues, service disruptions, and contract disputes, coordinating resolutions with internal stakeholders and vendor leadership.
  • Collaborate with Procurement, Legal, and Finance on contract renewals, amendments, pricing negotiations, and vendor performance assessments.
  • Ensure the managed service provider complies with security, compliance, data protection, and operational standards for printing services.
  • Manage the vendor relationship strategically, fostering partnership and continuous improvement while maintaining accountability for service delivery.
  • Own the global Office and M&S Printing Services budget, including hardware, software, managed service fees, consumables, and maintenance costs.
  • Develop annual budget forecasts with Finance, track actuals against budget monthly, and provide variance analyses and corrective action plans.
  • Optimize costs through vendor negotiations, consumption analysis, and cost-saving measures such as print-policy optimization and device rationalization.
  • Approve purchase orders, invoices, and financial commitments related to printing services within delegated authority.
  • Provide regular financial reporting to Digital leadership and Finance stakeholders, including cost per page, total cost of ownership, and return on investment metrics.
  • Ensure high-quality delivery of Office and M&S Printing Services across global sites, meeting or exceeding service quality targets.
  • Monitor device uptime, incident resolution time, user satisfaction, and service-request fulfillment rates.
  • Drive continuous improvement initiatives to enhance service reliability, user experience, and operational efficiency.
  • Oversee incident and problem management for printing services, ensuring timely resolution and root-cause analysis of recurring issues.
  • Coordinate with regional Digital teams and site stakeholders to address location-specific service needs and escalations.
  • Conduct service-quality audits and site visits, virtual or physical, to validate vendor performance and identify improvement opportunities.
  • Serve as Product Owner for Office and M&S Printing Services; define the strategic vision, product roadmap, and technology evolution in alignment with the company's Digital strategy.
  • Gather and prioritize requirements from business stakeholders, Digital teams, and end users to inform product development and service enhancements.
  • Define and maintain the printing-services technology roadmap, including hardware refresh cycles, software upgrades, security enhancements, and new capabilities such as mobile printing, secure print release, and cloud printing.
  • Evaluate emerging printing technologies and industry trends and recommend adoption or pilot programs to improve service value.
  • Collaborate with Enterprise Architecture, Security, and Infrastructure teams to align printing solutions with technical standards and security policies.
  • Manage the product backlog, prioritizing initiatives by business value, risk, cost, and strategic alignment.
  • Oversee the managed service provider's platform management services, including print server infrastructure, print management software, and monitoring tools.
  • Define platform performance requirements, availability targets, and technical standards for the outsourced printing platform.
  • Ensure the vendor maintains platform security, applies patches and updates, and follows change and incident management processes.
  • Coordinate platform upgrades, migrations, and technology refresh projects with the vendor while minimizing disruption to end users.
  • Monitor platform health, capacity, and performance metrics; escalate issues and drive resolution with the vendor.
  • Validate disaster recovery and business continuity plans for the printing platform to ensure resilience and compliance with IT standards.
  • Build and maintain trusted relationships with senior stakeholders across Digital, Finance, Procurement, and global business functions.
  • Serve as the primary contact and subject matter expert for Office and M&S Printing Services, providing consultative guidance to stakeholders.
  • Proactively communicate service updates, planned maintenance, incidents, and roadmap changes through regular stakeholder updates and governance forums.
  • Represent Printing Services in Digital governance meetings, leadership forums, and cross-functional planning sessions.
  • Manage stakeholder expectations through transparent communication, issue escalation, and post-incident reporting.
  • Represent the customer within the vendor relationship by translating business needs into service requirements and holding the vendor accountable for delivery.
  • Ensure printing services comply with information security policies, data protection regulations such as GDPR and HIPAA, and industry standards.
  • Collaborate with Security and Compliance teams to implement secure printing practices, including user authentication, print release, and data encryption.
  • Conduct risk assessments for printing services and mitigate risks related to data leakage, service availability, and vendor dependency.
  • Ensure vendor compliance with audit requirements and provide documentation and evidence for internal and external audits.
  • Own and communicate the scope boundary for Office and M&S Printing Services, including office Multi-Functional Printer print, scan, copy, and fax capabilities and M&S services such as Zebra, label, and thermal printers.
  • Proactively manage scope-creep risks and resolve scope-boundary disputes with stakeholders and the vendor.
Desired Qualifications
  • A Master's degree in a relevant field or an MBA is preferred.
  • ITIL Foundation or ITIL Expert certification, Product Management or Agile Product Owner certification, or relevant printing certifications are preferred.
  • Specific experience in Office Printing Services, Multi-Functional Printers, M&S Printing Services such as Zebra, label, and thermal printers, or print management platforms such as LMS, PaperCut, Equitrac, PrinterLogic, or similar is preferred.
  • Knowledge of cloud printing solutions and mobile printing technologies is preferred.
  • Experience with ServiceNow or similar IT service management tools is preferred.
  • Understanding of data security and compliance requirements for printing services, including GDPR and HIPAA, is preferred.
  • Experience with Agile/Scrum methodologies and product management frameworks is preferred.
  • Additional proficiency in Telugu or Hindi is advantageous for Hyderabad site engagement; English is mandatory.
  • Experience with Generative AI tools, machine learning algorithms, and AI-assisted automation is preferred.
  • Knowledge of output management solutions, such as LRS Output Management and Printing solutions in office and industrial environments, is preferred.
  • Experience in Agile is preferred.
  • Knowledge of network and cloud technologies is preferred.

About the company

Sanofi is a global pharmaceutical and biotechnology company that develops, manufactures, and sells prescription medicines, over-the-counter products, and vaccines. Its products span immunology, oncology, rare diseases, and vaccines, addressing unmet medical needs through a strong focus on research and development. Sanofi's core product model relies on large-scale R&D, strategic partnerships, and licensing to bring new therapies to markets, with revenue generated from product sales and collaborations. The company differentiates itself by leveraging its global reach, diverse portfolio, and emphasis on patient-centric solutions, safety, and quality to navigate regulatory environments in developed and emerging markets. The company’s goal is to improve health outcomes and quality of life for people worldwide by delivering innovative treatments and vaccines that meet unmet medical needs.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1973

Get referred to Sanofi

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • July 10, 2026 FDA approval of Sarclisa Escena created the first on-body cancer injector.
  • June 13, 2026 FDA accelerated approval expanded Tzield into recently diagnosed stage 3 T1D.
  • Q2 2026 sales grew 17.8% at CER, with Dupixent and Beyfortus leading.

What critics are saying

  • Texas sued Sanofi on February 19, 2026 over provider bribery and Medicaid fraud.
  • Sanofi sued Pfizer and Moderna on July 15, 2026, extending costly mRNA patent warfare.
  • Dupixent concentration makes 2030s patent loss an existential revenue shock.

What makes Sanofi unique

  • Dupixent reached €5.2 billion quarterly sales in Q2 2026 across nine indications.
  • October 1, 2026, Sanofi and Regeneron added four long-acting antibodies to their Alliance.
  • Sanofi's 61-project pipeline spans immunology, rare diseases, vaccines, neurology, and oncology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Professional Development Budget
  • Parental Leave

Company News

Associated Press
Oct 19th, 2026
Enable Injections wins first Japan approval for enFuse on-body injector via Sanofi's CirCLIQ

Enable Injections has won its first commercial product approval in Japan. The country's Ministry of Health, Labour and Welfare approved the company's enFuse On-Body Delivery System through Sanofi's CirCLIQ Injector. The device delivers a subcutaneous form of Sarclisa (isatuximab) with the push of a button, for treating multiple myeloma. It is the first anticancer treatment given through an on-body injector in Japan. The approval follows recent clearances in the US and Europe. Japan approved Sarclisa SC in June 2026, backed by the IRAKLIA phase 3 study, which showed the subcutaneous form was non-inferior to intravenous delivery. "We're proud to partner with Sanofi to bring our enFuse technology to patients in Japan," said Michael D. Hooven, chairman and chief executive officer of Enable.

Yahoo Finance
Oct 1st, 2026
Sanofi, Regeneron expand alliance in up to $8B deal for immunology drugs

France's Sanofi and US-based Regeneron Pharmaceuticals will expand their 20-year partnership to jointly develop and market immunology medicines in a deal worth up to $8 billion. Regeneron will receive $1 billion upfront, with potential additional payments of up to $7 billion tied to development, regulatory, and commercial targets. The collaboration will add four next-generation immunology drug candidates invented by Regeneron, with one currently in early-stage trials for eczema. The companies will equally share development costs and future profits from new drugs, whilst their existing profit-sharing agreement for top-selling medicine Dupixent remains unchanged. The deal settles prior litigation between the companies and marks an early move by Sanofi's new chief executive Belen Garijo to strengthen the company's pipeline.

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Vicebio

Sanofi completes acquisition of Vicebio Paris, December 4, 2025. Sanofi announces the completion of its acquisition of Vicebio Ltd (“Vicebio”). This acquisition brings an early-stage combination...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes acquisition of Blueprint Medicines

Sanofi completes acquisition of Blueprint Medicines Paris, July 18, 2025. Sanofi today announces the completion of its acquisition of Blueprint Medicines Corporation (Blueprint), adding to its...

Sanofi
Sep 20th, 2026
Press Release: Sanofi completes the acquisition of Dynavax

Sanofi completes the acquisition of Dynavax Paris, February 10, 2026. Sanofi today announced that it has completed the acquisition of Dynavax Technologies Corporation (Dynavax). The acquisition...